Also trades as: BBLG (NASDAQ) · $vol 0M
BBLGW NASDAQ
Bone Biologics Corporation
1W: +47.5%
1M: -0.2%
3M: -58.7%
YTD: -61.4%
1Y: -42.4%
3Y: +309109.2%
$5.99
+1.69 (+39.30%)
Weekly Expected Move ±29.3%
$2
$4
$6
$8
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$3M
+23.3% ▲
Net Income
-$3M
+24.4% ▲
EPS (Diluted)
$-2.65
+45.1% ▲
EBITDA
-$3M
-3001.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $82K | $2M | $7M | $2M | $1M |
| SG&A Expenses | $1M | $2M | $3M | $2M | $2M |
| Operating Expenses | $1M | $4M | $9M | $4M | $3M |
| Operating Income | -$1M | -$4M | -$9M | -$4M | -$3M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $805K | $732K | $0 | $0 | $0 |
| Income Before Tax | -$2M | -$1M | -$9M | -$4M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$1M | -$9M | -$4M | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-37.35 | $-31.20 | $-34.01 | $-4.83 | $-2.65 |
| EBITDA | -$806K | -$753K | $480K | $107K | -$3M |
| Shares Outstanding | 43127 | 47658 | 263137 | 2M | 1M |